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Abstract: Leishmaniasis and trypanosomiasis are parasitic diseases with a high infection rate, being a serious public health issue in the new 
world. Unfortunately, there are few available commercial drugs, poorly efficient and with increasing parasite resistance. Under these condi-
tions, there is a need for new molecules to develop new and better drugs. One approach to carry out this search is using traditional medicine 
as information source to obtain new molecules or extracts to control these parasite diseases. Sapindus saponaria (Sapindaceae) fruit resin is 
used in Colombia to treat ulcers caused by Leishmaniasis. In a bioguided study, we have analyzed the in vitro effect of fruit resin, chroma-
tographical fractions from fruit resin and also pure compounds against Leishmania species (L. panamensis, L. braziliensis, L. amazonensis 
and L. donovani) and Trypanosoma cruzi. The in vivo antileishmanial effect was established under the hamster model for cutaneous leish-
maniasis by L. panamensis; refined extract of S. saponaria and pure saponins displayed high in vitro and in vivo activity as leishmanicides. 
In addition, extracts caused low viability on T. cruzi amastigotes. The use of the crude extract can be a good alternative against cutaneous 
leishmaniasis, due to its activity, reduced hemolytic effect, and easy production procedures 
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Resumen: La Leishmaniasis y la tripanosomiasis son enfermedades parasitarias con una alta incidencia, siendo un serio asunto de salud 
pública en el nuevo mundo. Desafortunadamente, hay pocas drogas comerciales disponibles, con pobre eficiencia y con una creciente resis-
tencia parasitaria. Bajo esas condiciones, se necesitan nuevas moléculas para desarrollar nuevas y mejores drogas. Una aproximación para 
llevar a cabo esa búsqueda es usar la medicina tradicional como fuente de información para obtener nuevas moléculas o extractos para con-
trolar esas enfermedades parasitarias. La resina de Sapindus saponaria (Sapindaceae) se usa en Colombia para tratar úlceras causadas por la 
Leishmaniasis. En un estudio bioguiado, se analizó el efecto in vitro de varios extractos de la resina, sus fracciones cromatográficas y algu-
nos compuestos puros, contra varias especies de Leishmania  (L. panamensis, L. braziliensis, L. amazonensis y L. donovani) panamensis y 
Trypanosoma cruzi. El efecto lesihmanicida in vivo fue establecido usando el modelo en hamster de leishmaniasis cutánea producida por L. 
panamensis; los extractos refinados de S. saponaria y las saponinas puras mostraron alta actividad in vitro e in vivo como leishmanicidas. 
Además, los extractos causaron una baja viabilidad en amastigotes de T. cruzi. El uso de extractos refinados en vez de saponinas puras 
podría ser una buena alternativa contra leishmaniasis cutánea debido a su actividad, poco efecto hemolítico y procedimientos de producción 
mucho más fáciles. 
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INTRODUCTION 
Parasitic diseases caused by protozoan parasites such 
as Leishmania spp and Trypanosma cruzi are affect-
ting thousands of people around the world. Leish-
maniasis is a prevalent disease in 88 countries 
worldwide affecting 12 million people with 
1.500.000 new cases each year. It also accounts for 
500.000 cases of visceral leishmaniasis and 
1.500.000 of cutaneous leishmaniasis, and 
310.000.000 people at risk of infection (WHO. 
2014a). On the other hand, about 7.000.000-
8.000.000 million people are infected with T. cruzi in 
21 Latin-American countries, with approximately 
41.000 new cases per year (WHO. 2014b). 
 The massive displacement of population, 
weather change, growing resistance to drugs treat-
ment, lack of therapeutic alternatives and long treat-
ments are creating a significative rise in these di-
seases (Wilkinson & Kelly, 2009; Yasinzai et al., 
2013; Alsford et al., 2013) with resulting increases in 
public health problems mainly regarding to poor.  
 These diseases are almost neglected due to 
the low interest by big pharmaceutical companies to 
search and develop antiparasite compounds in this 
field, motivated by the small economic landscape that 
they represent as diseases with prevalence basically 
in developing countries. However, research on speci-
fic treatments against the parasite is a priority. There-
fore, is necessary, to search for new drugs from a 
different perspective to the pharmaceutical industry. 
Traditional medicine is an important source of infor-
mation of natural products and research based on this 
approach can provide both new molecules from 
promissory secondary metabolites and validation of 
ethnomedical uses of crude extracts or partially frac-
tionated through chemical methods. Natural product 
chemistry can offer new more molecules to develop 
drugs against these disease (Wink, 2012; Schmidt et 
al., 2012a; Schmidt et al., 2012b; Singh et al., 2014). 
 Sapindus resin and other type of saponin 
exhibit several biological activities, such as antihel-
mintic (Lal et al., 1976), molluscicide (Upadhyay & 
Singh, 2011), also possess antiprotozoal activity  
(Diaz et al., 1993). In Colombia, the resin is applied 
on the wound caused by leishmania (R. Fonnegra, 
Universidad de Antioquia, Botanical Garden, perso-
nal communication). Based on these facts, we set out 
to look for antiparasite substances from Colombian 
flora under bioguided studies, to determine the in 
vitro effect of the crude extract, several chromato-
graphical fractions and pure compounds of this plant 
resin against several Leishmania species (L. pana-
mensis, L. braziliensis, L. amazonensis and L. do-
novani) and Trypanosoma cruzi. In addition, to carry 
out in vivo assays for therapeutical response using the 
experimental model of cutaneous leishmaniasis in 
hamster experimentally infected with L. panamensis. 
 
MATERIALS AND METHODS 
General procedures 
NMR spectra were carried out on a Bruker AMX at 
300 MHz using Pyridin d-5 as solvent, and TMS as 
internal standard. Chemical shifts (δ) are reported in 
ppm and the coupling constants (J) in Hz. The high 
resolution mass spectra were obtained in a Waters 
Micro mass Q-TOF. Infrared spectra were acquired in 
a FTS 6000 (BioRad), the samples were prepared as 
KBr tablets. The melting points were taken in open 
capillaries using a Melt-Temp® (Electrothermal) 
device and are uncorrected. Column chromatography 
was carried out on silica gel 60 (200-300 mesh, 
Merck®) and Sephadex LH-20 (Sigma®), for thin 
layer chromatography silica gel 60 F254 impregnated 
aluminum sheets (0.25 mm, Merck®) were used. 
Compounds were detected under UV light (254, 360 
nm), spraying with H2SO4 (10%) and heating at 110º 
C. 
 
Plant material and extraction 
Sapindus saponaria fruit were collected in Medellín 
Colombia); a voucher specimen was deposited in the 
Herbarium at the University of Antioquia (HUA) 
under the identification code 156643. Dry fruits (3 
kg) were extracted with ethanol (96%), then filtered 
and the solvent evaporated under reduced pressure to 
dryness.  
 
Fractionation and purification of compounds 
The previously prepared crude extract was dissolved 
in a mixture of n-hexane-CH2Cl2-MeOH (2:1:1, v/v) 
and filtrated. The resulting solution was fractioned on 
Sephadex LH-20 using the same solvent mixture 
described above. The fractions were collected and 
combined according to their polarity profiles by tlc 
CH2Cl2-MeOH (9:1) as follow: non polar compounds 
(S1), medium polarity (2S, 3S, 4S) and polar com-
pounds (5S). The medium polarity fractions (2S, 3S, 
4S) were separated on a chromatographic column 
packed with silica gel 60 using CH2Cl2-MeOH mix-
ture as eluent, 4.5:0.5 v/v, until 1:1. From this step, 
five new fractions were collected (3S-B, 3S-C, 3S-D, 
3S-E, 3S-F); fractions 3S-B and 3S-C were mixed 
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and separated with repeated chromatographic col-
umns packed with silica gel 60 using CH2Cl2-MeOH 
(9:1) as eluent to give the pure compounds 1A (1.0 
g), 2A (0.6 g) and 3A (0.8 g) as white solids. The 
composition profile of each fraction was checked by 
tlc, eluting with CH2Cl2-MeOH (9:1) and H2SO4 
spraying with heating at 110 ºC. 
 
Acid hydrolysis of saponin mixture 
A mixture of saponins (10 g) was dissolved in 150 
mL of methanol and then 100 mL of distilled water 
were added. Four mL of HCl 0.1 N were added to the 
mixture and refluxed five hours at 90º C, after this 
time the methanol was removed and the resulting 
suspension was neutralized with K2CO3. Then ex-
tracted with ethyl acetate, the organic layer was dried 
over anhydrous Na2SO4 and the solvent evaporated to 
dryness, yielding 800 mg of a white solid highly so-
luble in pyridine, and identified as hederagenin by 
comparison of the spectroscopical data with those 
previously reported in the literature (Joshi et al., 
1999;  Kanchanapoom et al., 2001). 
 
In vitro Leishmanicidal activity 
The antileishmanial activity for the first five fractions 
(1S-5S) and sub-fractions from 3S (3SB-3SF) were 
tested on axenic and intracellular L. panamensis 
amastigotes, strain (MHOM/87/UA/UA140) trans-
fected with the green fluorescent protein gene (GFP) 
in agreement with methods previously reported  
(Varela et al., 2009)  
 The capacity of these chromatographical 
fractions in comparison to the meglumine antimo-
niate (Glucantime
®
, Sanofi-Aventis de Colombia) to 
kill axenic amastigotes of L. panamensis was deter-
mined based on the viability of the parasites evalua-
ted by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) method as described 
previously (Taylor et al., 2010). Briefly, parasites 
were cultivated in Schneider’s medium pH 5.4 sup-
plemented with 20% heat inactivated FBS for 3 days 
at 32º C. Afterwards they were harvested, washed 
and resuspended at 2 x 10
6
 axenic amastigotes/mL in 
fresh medium. Each well of a 96-well plate was seed-
ed with 100 µL of parasite suspension (in duplicate) 
and 100 µL of each concentration of the test com-
pound were added. Plates were incubated at 32 ºC. 
After 72 hours of incubation, the effect of drugs was 
determined by measuring the activity of the mito-
chondrial dehydrogenase by adding 10 L/well of 
MTT (Sigma) solution (0.5 mg/mL) and incubating at 
32 °C for 3 hours. The reaction was stopped by    
adding a 50% isopropanol solution with 10% sodium 
dodecyl sulfate for 30 min.  Cell viability was deter-
mined based on the quantity of formazan, which was 
measured with a Bio-Rad ELISA reader set at 570 
nm. Parasites cultivated in the absence of the com-
pound but maintained under the same conditions 
were used as controls for growth and viability. The 
results are expressed as Effective Concentration 50 
(EC50) by using a logarithmic regression with the 
probit method (Finney, 1978). The selectivity index 
(SI) was calculated by the quotient between citotoxi-
city on U937 cells and PM and leishmanicidal activi-
ty on axenic amastigotes (SI = LC50 / EC50 ). 
 The effect of all fractions and drugs against 
intracellular amastigotes of L. panamensis was eva-
luated by flow cytometry examination of infected 
PMA-induced U937 cells incubated in the presence 
or absence of each fraction and drug (Varela et al., 
2009; Pulido et al., 2012). After 72 hours growth 
PMA-induced U937 cells were exposed to pro-
mastigotes of GFP transfectant L. panamensis at a 
parasite:cell ratio of 35:1. The cells with the parasites 
were incubated for 2 hours 34 ºC, 5% CO2. Free para-
sites were removed by washing twice with PBS and 
fresh medium was added to the infected cells. Twen-
ty-four hours later medium was replaced with fresh 
medium containing the test compound and infected 
cells were exposed to the drug for 72 hours. The par-
asite load in presence and absence of the compounds 
was calculated from the ﬂuorescence intensities of 
CD33 and GFP positive infected macrophages. Tests 
were performed in two separate experiments and each 
concentration by triplicate. The results are expressed 
as Effective Concentration 50 (EC50), by using a lo-
garithmic regression with the probit method (Finney, 
1978). 
 The SI was calculated by the quotient be-
tween citotoxicity on U937 cells and PM and leish-
manicidal activity on intracellular amastigotes (SI = 
LC50 / EC50 ). 
 Antileishmanial activity of compounds 1A, 
2A, 3A and the crude extract of S. saponaria, was 
also evaluated on the promastigote stage of L. ama-
zonensis (IFLA/BR/75/PH8), L. braziliensis 
(MHOM/BR/75/M2903) and L. donovani 
(MHOM/74/PP75) reference strains (Instituto Bolivi-
ano de Biología de Altura) was determined according 
to the inhibition of parasite growth following the 
methodology described by Flores et al. (2008). The 
activity was calculated as viability percentage of the 
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treated parasites against the control. Results are ex-
pressed as Inhibitory Concentration 50 (IC50) derived 
from a typical dose response curve. 
 In vitro cultures of the promastigote stage of 
L. amazonensis, L. braziliensis, and L. donovani 
strains (Instituto Boliviano de Biología de Altura) 
were used to test compounds 1A, 2A, 3A and  the 
crude extract of S. saponaria, following the metho-
dology  described by Flores et al., (2008). Results are 
expressed as inhibitory concentration 50 (IC50) de-
rived from a typical dose response curve. 
 
In vivo test using the experimental model of cuta-
neous leishmaniasis Hamster/L. panamensis 
Therapeutic response and toxicity of compounds 
were evaluated in the experimental model of cuta-
neous leishmaniasis (hamster/L. panamensis) and 
their effects were compared to Glucantime®. Outbred 
adult (8-10- week-old, 140-160 g) Golden hamsters 
(Mesocricetus auratus) of both genders were used in 
all of the experiments (n = 5 per group). The animals 
were maintained under standard caging conditions 
and were provided with commercial rodent food and 
water ad libitum. The experiments were approved by 
the Ethic Committee for the Animal Experimentation 
of the University of Antioquia.  
 Under general anesthesia with Ketamine and 
Xylazine hydrochloride, the animals were inoculated 
intradermically in the snout with 100 mL of PBS 
alone or containing 1x10
6
 promastigotes of L. pana-
mensis (MHOM/CO/87UA140) obtained from a 5 
days culture. Initiation of treatment schedules took 
place seven - eight weeks after the inoculation when 
infection was well established, and lesions were   
conspicuous (Osorio et al., 2003; Robledo et al., 
2005; Flores et al., 2008; Varela et al., 2009). Com-
pounds were solubilized in carboxymethylcellulose 
and administered to hamsters at 40 mg/kg/d for 10 
days orally. A control group received daily carbox-
ymethylcellulose by oral administration. A second 
control group received and Glucantime® by intra-
muscular injections at a dose of 40 mg/kg/d for 10 
days. 
 Lesion size was measured prior to treatment 
and at days 15 and 30 after finished the treatment by 
measuring the diameter of the inoculated nose with a 
digital calibrator and expressed in millimeters. Their 
parasitological stage was determined by culture of 
material obtained from the lesions in NNN medium. 
At the end of the trial animals were also bled to quan-
tify serum level of BUN, creatinine and bilirrubin to 
detect any toxicity associated with the treatment. 
Animals were monitored during the study to detect 
any change in behavior or weight. At the end of the 
experiment hamsters were sacrified using a CO2 
chamber (as recommended by Ethical Committee for 
Animal Care) and the parasite burden was estimated 
by a semi-quantitative limiting dilution culture assay. 
The cervical lymph nodes and snouts were aseptically 
removed, weighed, and tritured in PBS supplemented 
with penicillin (100 U/mL), streptomycin (10 
mg/mL) and 10% of HIBFS. The tissue samples were 
adjusted to a concentration of 0.1 mg/mL of Schnei-
der’s medium, and 100 μL per well were distributed 
in flat-bottom microplates containing a layer of  NNN 
medium overlaid with a final volume of  100 μL 
Schneider’s medium. Samples were serially four-fold 
diluted up to 16,7 x 10
6
 and incubated for four weeks 
at 26 °C. Parasite burden was expressed as the maxi-
mum dilution in which parasites were detected by 
examination under an inverted microscope.  
 
Trypanocidal activity 
Compounds 1A, 2A, 3A and nifurtimox were dis-
solved in DMSO and added to a suspension of T. 
cruzi epimastigotes (3x10
6
/mL, strain MF). Parasite 
growth was monitored by nephelometry for a time 
period of 10 days. No toxic effect was observed for 
DMSO. 100% of viable parasites correspond to ab-
sorbance values measured from 570 to 690 nm per 
milligram of protein in the MTT assay without treat-
ed trypomastigotes (Faundez et al., 2005). The activi-
ty was calculated as viability percentage of the trea-
ted parasites against the control. 
 
In vitro Cytotoxic assay on mammal cells 
Cytotoxicity was evaluated for fractions 1S - 5S and 
3SB-3SF on the human promonocitic cell line U937 
(ATCC CRL-1593.2
TM
) and peritoneal macrophages 
(PM) from hamsters using a 96 well plate for cell 
culture as described previously (Taylor et al., 2011). 
Results are expressed as Lethal Concentration 50 
(LC50) calculated by the Probit method and co-
rresponds to the concentration at which 50% of the 
cell population died (Finney, 1978). 
 
Erythrocyte Hemolysis  
O+ human erythrocytes previously collected with 
CPD (anticoagulant solution) were centrifugated and 
washed twice with isotonic phosphate buffer (10 mM, 
pH 7.4)  at 500 g  x 5 min. The pellet was resuspen-
ded to 40% v/v with the same washing buffer. For 
Correa et al.  Leishmanicidal and trypanocidal activity of Sapindus saponaria  
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/315 
 
each compound, 200 µL of each concentration were 
added to the vial and then 4 µL of cells suspension 
(40%) were added, the final hematocrit was 0.8%. An 
isotonic solution (NaCl 150 mM) was used as basal 
hemolysis control and for maximal hemolysis 1% 
tween 20 was used. The suspension was incubated at 
37º C for 20 minutes. After this time, the samples 
were centrifugated at 500 g for 5 minutes and the 
supernatant transferred to a low affinity 96 well plate. 
The amount of free hemoglobin was determined    
reading spectrophotometrically at 540 nm (Micro-
plate reader, BIORAD 610). Hemolysis percentage 
was calculated with the equation % hemolysis = 
[(Sample Abs - NaCl Abs) / (Tween Abs - NaCl 
Abs)] * 100. Testing concentrations were 10 µg/mL, 
5 µg/mL, 2.5 µg/mL, 1.25 µg/mL and 0.625 µg/mL 
in DMSO. 
 
  
 
RESULTS  
Compounds structure 
The crude extract of S. saponaria by thin layer chro-
matography exhibited a triterpene profile, in addition 
to presence of high amounts of sugars. Compounds 
1A, 2A and 3A (Figure 1) possess the same triterpene 
moiety. The isolated saponin mixture subjected to 
acid hydrolysis allowed identification of hederagenin 
as aglycone, by comparing their spectroscopic data  
with those previously reported (Joshi et al., 1999; 
Kanchanapoom et al., 2001). 
 All compounds were identified through 
1
H 
NMR, 
13
C NMR and experiments COSY 
1
H-
1
H, 
JMOD, HMQC and HMBC. Compound 1A is, there-
fore, the hederagenin-3-O-(3,4-O-diacetyl-ß-D-
xylopyranosyl)-(1-->3)-α-L-rhamnopyranosyl-(1--
>2)-α-L-arabinopyranoside previously reported 
(Murgu & Rodrigues-Filho, 2006); in addition, com-
pounds 1A, 2A and 3A were also isolated from Gliri-
cidia sepium (Kojima et al., 1998). 
 
Table 1 
Activity on amastigotes of L. panamensis of chromatographic fractions  
from S. saponaria crude extract 
Treatment Fraction 
LC50 (µg/mL) 
U937 cells 
Inhibition % at 50µg/mL 
 Crude extract   47.2 57.0 
Crude extract fractionation on sephadex LH-20. 
2-S   19.7 96.8 
3-S   10.3 76.0 
4-S   67.5 64.3 
5-S 462.2 47.1 
 
Fraction 3S separation on Silica gel 60 
3S-B   13.9 97.5 
3S-C <15.6 92.1 
3S-D    8.2 92.1 
3S-E 152.9 82.1 
3S-F 355.2 58.5 
Glucantime®  400 50 
 
 
 The difference in the structure of the com-
pounds is mainly due to the kind of sugar compo-
nents and the number of acetoxyl groups in the gly-
cosidic chain (Figure 1). For compound 1A, sugar 
residues follow the sequence Ara-Rha-Xyl (the last 
diacetylated), saponin 2A has the sequence Ara-Rha-
Ara as can be deduced from the multiplicity of the 
proton at C-4, which appear as a broad singlet instead 
of a double triplet as it is the case for xylose. In the 
last sugar component of the sequence of compound 
2A, diacetoxylation at C-3 and C-4 is found, accor-
ding to cross peaks between the protons at these posi-
tions and the acetoxyl carbonyls signals. For com-
pound 3A, the sequence and sugar type is the same as 
in compound 1A, but the difference is the acetylation 
only at C-4 of the xylose unit. 
 
Correa et al.  Leishmanicidal and trypanocidal activity of Sapindus saponaria  
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/316 
 
Hederagenin-3-O-(3,4-O-diacetyl-ß-D-
xylopiranosyl-(1-->3)-α-L-rhamnopyranosyl-(1--
>2)-α-L-arabinopyranoside (1A) 
White solid. mp. 190-192ºC. IR (KBr cm
-1
): 3448 
(broad), 2944, 1741, 1384, 1250, 1250. HR ESI-TOF 
MS, m/z 967.5067 [M + H], calcd for C50H78O18  
967.5222 [M + H].  
 
Hederagenin-3-O-(3,4-O-diacetyl-α-L-
arabinopyranosyl-(1-->3)-α-L-rhamnopyranosyl-(1-
->2)-α-L-arabinopyranoside (2A) 
White solid. mp. 193-195ºC. IR (KBr cm
-1
): 3447 
(broad), 2943, 1733, 1384, 1242, 1053. HR ESI-TOF 
MS, m/z 967.5416 [M + H], calcd for C50H78O18  
967.5222 [M + H]. 
 
Hederagenin-3-O-(4-O-diacetyl-ß-D-xylopiranosyl-
(1-->3)-α-L-rhamnopyranosyl-(1-->2)-α-L-
arabinopyranoside (3A) 
White solid. mp. 195-197ºC. IR (KBr cm
-1
): 2942, 
1734, 1386, 1253, 1053. HR ESI-TOF MS, m/z 
925.5466 [M + H], calcd for C48H76O17  925.5116 [M 
+ H]. 
 Hederagenin. White solid. mp. 333-335, IR 
(KBr cm
-1
): 3451, 2943, 1698, 1386, 1037.  
 
Leishmanicidal activity of fractions and isolated 
compounds from S. saponaria 
Activity on L. panamensis amastigotes   
The crude extract from ripe fruit of S. saponaria was 
separated in 5 fractions (1S - 5S) through column 
chromatography using Sephadex LH-20; these frac-
tions were evaluated at 50 µg/mL on L. panamensis 
amastigotes. The crude extract has a significant inhi-
bitory activity (57% of inhibition) and low toxicity, 
47.2 µg/mL, (Table 1). Fraction 2S showed a high 
percentage of inhibition (96.8%) and a LC50 of 19.7 
µg/mL, fraction 3S has high inhibitory activity (76%) 
and a LC50 of (10.3 µg/mL), whereas 4S has 64.3% 
of inhibition but is less cytotoxic (LC50 67.5 µg/mL). 
Fractions 1 and 5 were practically inactive in 
amastigotes of L panamensis. 
 According to these results and the similarities 
observed among the fractions by thin layer chroma-
tography, fractions 2S, 3S and 4S were combined. 
From this mixture five new fractions were obtained 
(3S-B, 3S-C, 3S-D, 3S-E, 3S-F), almost all of which 
were over 80% active on amastigotes, being 3S-E the 
least cytotoxic (152.9 µg/mL, Table 1). However, 
yields from 3S-E fraction were the lowest and its 
composition was rich in high amounts of sugars; 
though, it still contained the same compounds of the 
other three fractions. 
 Fractions 3S-B and 3S-C were mixed and 
after several chromatographical procedures three 
compounds were purified (1A, 2A, 3A) and their 
structures assigned by spectroscopical methods. Simi-
larly, fractions 3S-E and 3S-F were also mixed. 
 Compounds 1A, 2A and 3A, their aglycone 
hederagenin, and the crude extract were evaluated on 
axenic and intracellular amastigotes. It was observed 
that intracellular parasites were more sensitive than 
axenic amastigotes to the tested compounds (Table 
2). At low concentrations, all pure compounds and 
the crude extracts were highly activity against intra-
cellular amastigotes, but less active against axenic 
amastigotes; however, cytotoxicity in U937 cells was 
higher. The small differences in the structure of com-
pounds 1A, 2A and 3A do not change their potency 
significantly (Table 2), and glycosilation level does 
not account for an important change in the activity as 
can be seen when comparing the results with those 
for hederagenin. Nevertheless, glycosilation must be 
important in the in vivo experiments possibly by in-
creased in absorption. 
 
Activity on several species of Leishmania pro-
mastigotes 
With the aim to determine the biological effect on 
several species of Leishmania and metabolic stages 
of the parasites, compounds 1A, 2A and 3A were 
evaluated (Table 3). L. donovani was the less sensi-
tive to the effects of the tested compounds with an 
IC50 value of 68 µg/mL for all pure compounds, but it 
was slightly more sensitive to the crude extract with 
IC50 35.3 µg/mL. In the case of L. braziliensis and L. 
amazonensis promastigotes, a higher sensitivity to all 
compounds was detected; though an inexplicable 
resistance to compound 2 was noticed (Table 3). Ap-
parently, there is no need to get pure compounds, and 
that a semi-processed extract with less amounts of 
sugar could be a promissory material to start other 
experiments related to the in vivo effects, and to de-
velop a formulation against leishmaniasis. This is an 
advantage since complex, expensive and time con-
suming purification technologies will not be required 
to get active components. 
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Table 2 
Cytotoxicity and leishmanicidal activity of compounds 1A, 2A, 3A, hederagenin and the crude    
extract on peritoneal macrophages, and human promonocitic cells U937.  
Results are expressed as mean ± SD. n = 2 
 
 
Substance 
 
LC50 (µg/mL) EC50 (µg/mL) 
IS
a
  
U937,  PM 
 U937 PM
b AAc IA
 
AA IA 
1A   1.3 ± 0.3 15.3 ± 2.2   8.6 ± 2.3    2.5 ± 0.3 0.2, 1.8   0.5, 6.12 
2A   2.2 ± 0.4 10.1 ± 1.8 16.6 ± 0.1    2.7 ± 0.6 0.1, 0.6 0.8, 3.7 
3A   3.7 ± 0.4 11.1 ± 0.1 10.8 ± 1.1    2.1 ± 0.2 0.3, 1.0 1.8, 5.3 
Hederagenin 13.5 ± 3.0 29.6 ± 4.0 18.1 ± 1.5  10.7 ± 1.8 0.7, 1.6 1.2, 2.1 
C Ex
e 26.3 ± 1.7 34.7 ± 5.1 57.7 ± 0.6  14.5 ± 0.8 0.5, 0.6 1.8, 2.4 
a
 IS: Index of selectivity = CL50/EC50; 
b
 PM: peritoneal macrophages; 
c
 AA: Axenic Amastiogotes:  
d
 IA: Intracellular Amastigotes; 
e
 CEx: Crude Extract 
 
 
 
 
 
 
 
Table 3  
Leishmanicidal activity on promastigotes of different species of isolated saponins  
from Sapindus saponaria 
Substance IC50 (µg/mL) 
Specie/strain L. amazonensis PH8 L. brazilensis M2903 L. donovani PP75 
Crude extract   23.4 ± 0.007 32.0 ± 0.14 35.35 ± 3.88 
1A 23.0 ± 0.56 32.0 ± 0.21 68.30 ± 0.49 
2A 68.4 ± 0.35 32.4 ± 0.28 68.60 ± 0.14 
3A 23.2 ± 0.28 28.1 ± 0.42 66.30 ± 1.34 
 Amphotericin IC50: 0.2 µg/mL     Pentamidine IC50: 10 µg/mL 
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Table 4 
Effect of S. Saponaria fractions on the lesion size (snout) and parasite load in the experimental 
model of cutaneus leishmaniasis (Hamster/L. panamensis). 
Treatment Lesion size
a
 (mm
2
  SD) % reduc-
tion lesion 
b 
 
% reduc-
tion para-
site load
 
 
Preinfection Pre treat-
ment 
30 days post-
treatment 
 
Crude extract (3S)  
16.9 ± 0.9 
 
18.7 ± 1.5 
 
20.9 ± 2.9 
0 0 
3S-E,F 13.6 ± 0.5 16.4 ± 1.8 18.7 ± 3.1 0 14.3 
3S-D 14.3 ± 0.8 20.0 ± 4.9 20.0 ± 1.6 0 31.0 
CMC
c
 16.2 ± 1.6 21.2 ± 3,4 18.1 ± 5.8 14.6 0 
Glucantime® 15.4 ± 0.8 18.6 ± 0.3 15.5 ± 0.4 16.6 100 
Control  
(uninfected/ untreated) 
12.5 ± 0.4 13.5 ± 0.3 14.1 ± 0.3 
0 NA
d
 
a. Lesion size: Area of induration 
b. %reduction lesion size = 100 – [(Lesion size 30 days post-treatment/lesion size pre-treatment) x 100] 
c. CMC: carboxymethylcellulose 
d. Not apply. 
 
Antileishmanial effect in the animal model 
The main mixtures of saponins, i.e. chromatogram-
phical fraction 3S-D, the crude extract and fractions 
3S-E-F, were tested in an in vivo assay against L. 
panamensis, considering the previously described in 
vitro results and using the experimental model of 
cutaneous leishmaniasis in the hamster model,     
according to modifications on the size of the  ulcer 
and the parasite load in the snout. 
 The in vivo results showed that the chroma-
tographical fraction 3S-E-F and the crude extract did 
not influence the wound evolution caused by para-
sites; however, a decrease in parasitaemia of 14.3% 
was observed for 3SE-3SF. Fraction 3S-D delayed 
the wound evolution (Table 4) and parasitaemia was 
reduced in 31.0% in comparison to the control. Glu-
cantime® (40 mg/Kg, IM) showed absence of para-
sites 15 days postreatment and 100% decreased in 
parasitaemia. 
 The biochemical assays before and after 
treatment with compounds indicated the absence of 
toxic effects with the application of these extracts,
 
Trypanocidal activity of crude extract and saponins 
1A and 2A from S. saponaria 
Compounds 1A, 2A and the crude extract were tested 
on Trypanosoma cruzi epimastigotes to evaluate their 
activity. This assay was carried out in two ways; first, 
using the compounds or crude extract alone at 1.44, 
and 0.288 mg/mL for compound 1A, 0.208 mg/mL 
for compound 2A and 2.8 mg/mL for crude extract, 
and second adding nifurtimox, one of the drugs of 
choice for the treatment of trypanosomiasis, at the 
same concentrations of the previously described 
compounds. When the effect of nifurtimox was eva-
luated against the parasites, the viability was 78.02%, 
indicating probably a resistant strain (Table 5). Com-
pounds 1A and 2A displayed the lowest percentages 
of viability; compound 1A was the most effective 
with values of 5.85% (1.44 mg/mL) and 6.21% 
(0.208 mg/mL) with and without the addition of ni-
furtimox, respectively. The results were similar for 
the lowest concentration tested on compound 1A. The 
activity related to the crude extract was 30.63 and 
29.67% (plus nifurtimox) of viability. These results 
suggest lack of synergism among compounds tested 
and nifurtimox, because their viability is very similar 
and we could only see a very small increase in activi-
ty when the compounds were assayed together. 
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Table 5 
Effect of crude extract and saponins 1A and 2A on Trypanosoma cruzi  
viability with and without adding Nifurtimox 
Compound % of viability
a
 Concentration (mg/mL) 
Control 100,00 ± 0,17  
Nx
b
    78,00 ± 0,06 10  µM 
Crude extract    30,63 ± 0,07 2,8 
Crude extract + Nx   29,67 ± 0,08 2,8 
1A      6,21 ± 0,01 1,44 
1A + Nx     5,85 ± 0,01 1,44 
2A      9,86 ± 0,01 0,208 
2A + Nx     6,92 ± 0,01 0,208 
1A      8,13 ± 0,02 0,288 
1A + Nx   11,30 ± 0,01 0,288 
ªMean value + Standard deviation; 
b
Nifurtimox. 
 
Hemolysis 
With the aim to establish the hemolytic capability of 
these substances due to their triterpene moiety, the 
crude extract and compounds 1A, 2A and 3A were 
evaluated at five concentrations (Figure 2). All com-
pounds caused 100% hemolytic effect at 10 µg/mL, 
but at the same concentration the crude extract 
showed a low hemolytic action (4.64%). Compound 
1A produced 89% hemolysis at 5.0 µg/mL. This ef-
fect dropped when the concentration was decreased 
to 2.5 µg/mL; at lower concentrations no significant 
changes in the hemolytic effect were observed, re-
maining under 4%. This effect could be due to low 
concentration of these triterpenes in some chromato-
graphical fractions or crude extracts and the presence 
of high amounts of sugars.  
 
DISCUSSION 
Research on natural products is an important source 
of new molecules with therapeutic potential in the 
treatment of a broad number of diseases, among them 
parasitic diseases such as leishmaniasis and trypano-
somiasis, which have been neglected (Davis et al., 
2004; The Lancet, 2014). 
 Sapindus saponaria has been reported to be 
used in stomachal ulcer treatment skin lesions and 
inflammation (Meyer et al., 2002; Guirado & Orlan-
do, 2005). In Colombia, the resin is applied on the 
wound caused by leishmania; this biological activity 
is in agree to this results, since antiparasite activity in 
crude extracts, fractions and pure compounds has 
been detected, both in vitro and in vivo experiments. 
In addition, from the crude extract of Sapindus sapo-
naria, three pure triterpene saponins were isolated 
and their structure was elucidated by spectroscopic 
methods. These type of molecules are characterized 
by the presence of several sugar units. 
 The crude extract, chromatographical frac-
tions and pure compounds have different levels of 
activity against L. panamensis and T. cruzi. In pre-
liminary bioassays the crude extract and the chroma-
tographical fractions were found to exhibit good 
leishmanicidal activity and lower cytotoxicity than 
the pure compounds. After that, compounds were 
purified and then assayed against L panamensis; all 
compounds displayed high and similar  leishmanicid-
al activity to those results established with refined 
extracts. But in fact, these chromatographical frac-
tions are saponins rich mixtures with different ratios 
and they are susceptible to standardization in two 
important aspects, their chemical composition and 
biological activity. The process to purify and obtain 
only pure compounds is slow and expensive, in con-
trast to the extracts, but the level of bioactivity of the 
refined extract is almost the same as that of the pure 
molecules.  
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Figure 1 
Structure of saponins isolated from Sapindus saponaria and HMBC  
connectivities in carbohydrate moiety 
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The assays carried out under the animal model gave 
promissory results, considering that the structure of 
the compounds has not been optimized neither their 
concentrations, frequency and administration route. 
From this study, it is clear that in the time course of 
the experiments and at the concentration used, no 
associated toxicity appeared. The crude extract prac-
tically has not hemolytic action. Thus, the use of he-
molytic saponins could be implemented in the treat-
ment of cutaneous leishmaniasis, using optimized 
topical formulations, and as such hemolysis is not a 
pharmacological problem anymore. Other leishmani-
cidal saponins have been already studied up to very 
advanced levels, but their studies did not go any fur-
ther because observed cytotoxicity (Germonprez et 
al., 2005). 
 
 
Figure 2 
Hemolytic activity of crude extract and compounds 1A, 2A and 3A from S. saponaria 
 
 
 
 
 On the other hands, significative reduction of T. 
cruzi viability was obtained with application of low 
concentration of refined extracts from S. saponaria. 
Lower values like 6.21% reduction are caused with 
application of extract 1A, but did not reduced in a sig-
nificant way this value when was applied together ni-
furtimox, a control positive drug. Similar profile of 
activity was detected with the application of extract 2A. 
These results were causes despite the presence of a high 
resistant strain of T cruzi, because in this experiment, 
nifurtimox at 10 mM, only caused a slight reduction in 
the viability. 
 Finally, a highlight of this research was the 
possibility of obtaining refined extracts more than pure 
compounds, to apply in some diseases, since, as is well 
known, possibilities like ADME properties and syner-
gism, could be expressed. In addition, chemical purifi-
cation methods involve a lot of time and budget, to 
obtain a few milligrams of the active molecule. Moreo-
ver,  sensitivity and accepted or ruled concentrations 
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levels to consider a material as promissory are relative 
to each lab or to each experiment (including culture 
media and lab conditions), since the behavior parasite 
strains is sometimes variable (Pink et al., 2006). Be-
sides, the availability of raw material to produce more 
refined extract or pure compounds is guaranteed, be-
cause a tree can produce up to 500 kg of fruit per year, 
and lately is cultivated in several reforestation pro-
grams. 
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